| Bioactivity | GSK3335103 is an orally active, non-peptide αvβ6 integrin inhibitor (pIC50=8). GSK3335103 can be used in the study of pulmonary fibrosis[1]. |
| CAS | 1893340-21-0 |
| Formula | C27H36FN3O4 |
| Molar Mass | 485.59 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Procopiou P A, et al. Discovery and Development of Highly Potent and Orally Bioavailable Nonpeptidic αvβ6 Integrin Inhibitors[J]. Journal of Medicinal Chemistry, 2024. |
GSK3335103
CAS: 1893340-21-0 F: C27H36FN3O4 W: 485.59
GSK3335103 is an orally active, non-peptide αvβ6 integrin inhibitor (pIC50=8). GSK3335103 can be used in the study of
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.